Page last updated: 2024-09-04

pralnacasan and docetaxel

pralnacasan has been researched along with docetaxel in 1 studies

Compound Research Comparison

Studies
(pralnacasan)
Trials
(pralnacasan)
Recent Studies (post-2010)
(pralnacasan)
Studies
(docetaxel)
Trials
(docetaxel)
Recent Studies (post-2010) (docetaxel)
1907101033

Protein Interaction Comparison

ProteinTaxonomypralnacasan (IC50)docetaxel (IC50)
Tubulin beta-4A chainHomo sapiens (human)0.5
Tubulin beta chainHomo sapiens (human)0.5
Cytochrome P450 3A4Homo sapiens (human)2
Tubulin alpha-3C chainHomo sapiens (human)0.5
Substance-K receptorHomo sapiens (human)1.563
Tubulin alpha-1B chainHomo sapiens (human)0.5
Tubulin alpha-4A chainHomo sapiens (human)0.5
Tubulin beta-4B chainHomo sapiens (human)0.5
Growth hormone-releasing hormone receptorHomo sapiens (human)0.0001
Tubulin beta-3 chainHomo sapiens (human)0.5
Tubulin beta-2A chainHomo sapiens (human)0.5
Tubulin beta-8 chainHomo sapiens (human)0.5
Tubulin alpha-3E chainHomo sapiens (human)0.5
Tubulin alpha-1A chainHomo sapiens (human)0.5
Tubulin alpha-1C chainHomo sapiens (human)0.5
Tubulin beta-6 chainHomo sapiens (human)0.5
Tubulin beta-2B chainHomo sapiens (human)0.5
Tubulin beta-1 chainHomo sapiens (human)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1

Other Studies

1 other study(ies) available for pralnacasan and docetaxel

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
chemdatabank.com